Cargando…

Novel tumour markers: a diagnostic role in pancreatic cancer?

Detalles Bibliográficos
Autor principal:	Roulston, J. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1994
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033348/ https://www.ncbi.nlm.nih.gov/pubmed/8080718

Ejemplares similares

Microelements as diagnostic markers of pancreatic cancer
por: Lener, Marcin, et al.
Publicado: (2015)

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.
por: Haglund, C., et al.
Publicado: (1986)

Pembrolizumab‐related pancreatitis with elevation of pancreatic tumour markers
por: Kakuwa, Tamaki, et al.
Publicado: (2020)

Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis
por: An, Taixue, et al.
Publicado: (2015)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

Increased N-glycosylation of Asn(88) in serum pancreatic ribonuclease 1 is a novel diagnostic marker for pancreatic cancer
por: Nakata, Daisuke
Publicado: (2014)

CAM 17.1--a new diagnostic marker in pancreatic cancer.
por: Gansauge, F., et al.
Publicado: (1996)

MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers
por: Cheng, Wei-Tzu, et al.
Publicado: (2017)

Diagnostic value of tumour markers in pleural effusions
por: Volarić, Darian, et al.
Publicado: (2018)

Tumour markers in breast cancer.
por: Cove, D. H., et al.
Publicado: (1979)

Diagnostic ability of deep learning in detection of pancreatic tumour
por: Dinesh, M. G., et al.
Publicado: (2023)

Role of tumour markers in monitoring epithelial ovarian cancer
por: Meyer, T, et al.
Publicado: (2000)

Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes
por: Binang, Helen B., et al.
Publicado: (2023)

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer
por: Lerbs, Tristan, et al.
Publicado: (2017)

Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
por: Pasanen, P. A., et al.
Publicado: (1992)

Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA.
por: Haglund, C.
Publicado: (1986)

Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer
por: Słotwiński, Robert, et al.
Publicado: (2017)

Soluble B7-H5 Is a Novel Diagnostic, Severity, and Prognosis Marker in Acute Pancreatitis
por: Xu, Ruoxin, et al.
Publicado: (2021)

The role of carbohydrate antigen 19-9 as a tumour marker of oesophageal cancer.
por: McKnight, A., et al.
Publicado: (1989)

Continuous chemotherapy in responsive metastatic breast cancer: a role for tumour markers?
por: Dixon, A. R., et al.
Publicado: (1993)

Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
por: Hajri, A., et al.
Publicado: (1998)

UHRF1 is a novel diagnostic marker of lung cancer
por: Unoki, M, et al.
Publicado: (2010)

NY-ESO-1 antibody as a novel tumour marker of gastric cancer
por: Fujiwara, S, et al.
Publicado: (2013)

The value of tumour markers in lung cancer.
por: Gomm, S. A., et al.
Publicado: (1988)

CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
por: Haglund, C., et al.
Publicado: (1994)

aP2 Protein Expression as a Diagnostic Marker in Soft Tissue Tumours
por: Yang, T. T., et al.
Publicado: (2001)

Serum proteins as tumour markers for breast cancer.
por: Mattison, P., et al.
Publicado: (1981)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

The role of DNA methylation in human pancreatic neuroendocrine tumours
por: English, Katherine A, et al.
Publicado: (2023)

Impact of tumour associated macrophages in pancreatic cancer
por: Mielgo, Ainhoa, et al.
Publicado: (2013)

MYB is a novel regulator of pancreatic tumour growth and metastasis
por: Srivastava, Sanjeev K, et al.
Publicado: (2015)

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer
por: Martinelli, Paola, et al.
Publicado: (2017)

N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
por: Shrivastav, Anuraag, et al.
Publicado: (2007)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer
por: Srivastava, K., et al.
Publicado: (2023)

Assessing tumour markers.
por: Tate, H.
Publicado: (1981)

DRH1 – a novel blood-based HPV tumour marker
por: Weiland, Thomas, et al.
Publicado: (2020)

GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma
por: Yang, Sen, et al.
Publicado: (2022)

Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
por: Li, Qing, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9l6e7vkohh8sml2b3knhm6qmpt